Lafutidine - CAS 118288-08-7
Catalog number: 118288-08-7
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
Histamine Receptor
Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion.
1.Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats.
Yamamoto H1, Ishihara K2, Takeda Y2, Koizumi W1, Ichikawa T2. Biomed Res Int. 2013;2013:276186. doi: 10.1155/2013/276186. Epub 2013 Dec 23.
AIM: Gastrointestinal mucositis is a frequent complication of antineoplastic chemotherapy, but the effects of chemotherapy on mucosal defense mechanisms remain poorly understood. We studied the effects of cisplatin on mucin, one of the principal defense factors of the gastrointestinal mucosa, and evaluated the efficacy of two different types of H2-receptor antagonists against cisplatin-induced mucositis.
2.Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria.
Ogawa Y1, Ichinokawa Y, Hiruma M, Machida Y, Funakushi N, Sadamasa H, Hiruma M. J Dermatolog Treat. 2013 Dec;24(6):463-5. doi: 10.3109/09546634.2013.800183. Epub 2013 May 21.
We conducted a retrospective cohort study evaluating the efficacy and usefulness of the addition of lafutidine, a novel histamine H2-receptor antagonist, in treatment of patients with idiopathic chronic urticaria whose disease was not well controlled with histamine H1-receptor antagonists. Based on the assessment of global improvement, moderate or better improvement was achieved in 39 of 46 patients (85%) after 1-3 weeks of additional administration of lafutidine and 35 patients (76%) after 3 months. No incidence of drug-related adverse reactions was reported in any patient. Lafutidine was rated as useful or better in 34 patients (74%) after 3 months of treatment. The usefulness of the drug was not affected by differences in background factors, such as disease duration, previous treatment duration and the number of concomitant H1-receptor antagonists. Lafutidine appears to be a promising addition to histamine H1-receptor antagonist therapy for the treatment of chronic urticaria resistant to treatment with H1-receptor antagonists alone.
3.Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
Patil S1, Talele GS. Drug Deliv. 2015 May;22(3):312-9. doi: 10.3109/10717544.2013.877099. Epub 2014 Jan 29.
Lafutidine a newly developed histamine H2-receptor antagonist having biological half-life of 1.92 ± 0.94 h due to its selective absorption from upper part of gastrointestinal tract the development of mucoadhesive sustained release drug delivery system is recommended in order to enhance the bioavailability. A mucoadhesive tablets was developed using the natural polymer, sodium alginate, xanthan gum and karaya gum. Mucoadhesion is a complex phenomenon which involves wetting, adsorption and interpenetration of polymer chains. The prepared tablets of various formulations were evaluated for a total mucoadhesion time, buoyancy lag time and percentage drug released. The formulation with xanthan gum showed better results. Thus, it may be useful for prolonged drug release in stomach to improve the bioavailability and reduced dosing frequency. Non-fickians release transport was confirmed as the drug release mechanism from the optimized formulation by Korsmeyer-Peppas.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products

CAS 32385-58-3 Imetit dihydrobromide

Imetit dihydrobromide
(CAS: 32385-58-3)

Imetit dihydrobromide is a potent and high affinity agonist at histamine H3 and H4 receptors (Ki = 0.3 and 2.7 nM, respectively). It induces an eosinophil shape...

CAS 113-69-9 Benzquinamide Hydrochloride

Benzquinamide Hydrochloride
(CAS: 113-69-9)

Benzquinamide hydrochloride is an antiemetic compound with antihistaminic, anticholinergic and sedative properties. The mechanism of action is not quite sure an...

CAS 140873-26-3 Aminopotentidine

(CAS: 140873-26-3)

Aminopotentidine is a high selectivity and high affinity histamine H2 receptor antagonist. Its KB values are 220 and 280 nM at human and guinea pig H2 receptors...

CAS 15686-51-8 Clemastine

(CAS: 15686-51-8)

Clemastine is a histamine H1 antagonist commonly used for the symptoms of allergic rhinitis, hay fever, and cold.

CAS 145196-87-8 Iodophenpropit dihydrobromide

Iodophenpropit dihydrobromide
(CAS: 145196-87-8)

Iodophenpropit dihydrobromide is a selective and high affinity histamine H3 antagonist (KD = 0.3 nM).

CAS 154-69-8 Tripelennamine hydrochloride

Tripelennamine hydrochloride
(CAS: 154-69-8)

Tripelennamine hydrochloride, the hydrochloride salt form of tripelennamine, is a blood-brain barrier penetrant and orally active H1-receptor antagonist. Tripel...

CAS 142457-00-9 Amthamine dihydrobromide

Amthamine dihydrobromide
(CAS: 142457-00-9)

Amthamine dihydrobromide is the dihydrobromide salt of amthamine, which is a highly selective histamine H2 receptor agonist. It is a weak antagonist at H3 and h...

CAS 929622-08-2 Bavisant

(CAS: 929622-08-2)

Bavisant is a highly selective, orally active antagonist of the human H3 receptor. It is a novel mechanism of action, involving wakefulness and cognition. It ha...

CAS 868698-49-1 (R)-(-)-alpha-Methylhistamine dihydrobromide

(R)-(-)-alpha-Methylhistamine dihydrobro
(CAS: 868698-49-1)

(R)-(-)-alpha-Methylhistamine dihydrobromide is a potent and high affinity histamine H3 agonist (KD = 50.3 nM) displaying > 200-fold selectivity over H4 recepto...

CAS 5053-06-5 Fenspiride

(CAS: 5053-06-5)

Fenspiride is an α adrenergic and H1 histamine receptor antagonist. It is an oxazolidinone spiro compound. It is used as a drug in the treatment of certain resp...

CAS 14976-57-9 Clemastine Fumarate

Clemastine Fumarate
(CAS: 14976-57-9)

Clemastine Fumarate (Clemastine) is a selective histamine H1 receptor antagonist with IC50 of 3 nM.

CAS 442-52-4 Clemizole

(CAS: 442-52-4)

Clemizole is an H1 antagonist acts as a TRPC5 channel blocker (IC50 values are 1.1, 6.4, 9.1, 11.3 and 26.5 μM for TRPC5, TRPC4, TRPC3, TRPC6 and TRPC7 respecti...

CAS 100981-43-9 Ebrotidine

(CAS: 100981-43-9)

Ebrotidine(FI 3542), a competitive H2-receptor antagonist, has gastroprotective activity under the condition of gastric mucosal damage caused by some stress res...

CAS 76963-41-2 Nizatidine

(CAS: 76963-41-2)

Nizatidine is a histamine H2 receptor antagonist with IC50 of 0.9 nM, also inhibits AChE with IC50 of 6.7 μM.

CAS 1049740-32-0 A 331440 dihydrochloride

A 331440 dihydrochloride
(CAS: 1049740-32-0)

A 331440 dihydrochloride is a histamine H3 receptor antagonist (Ki = 21.7 and 22.7 nM for rat and human H3 receptors, respectively). A 331440 reduces weight in ...

CAS 82-93-9 Chlorcyclizine

(CAS: 82-93-9)

Chlorcyclizine is a first-generation Histamine Receptor antagonist of the phenylpiperazine class. It can be used primarily to treat allergy symptoms such as rhi...

CAS 10246-75-0 Hydroxyzine pamoate

Hydroxyzine pamoate
(CAS: 10246-75-0)

Hydroxyzine pamoate, a derivative of hydroxyzine, is a histamine H1-receptor antagonist that has been used as anxiolytic and antihistaminic so that it is probab...

CAS 129-74-8 Buclizine hydrochloride

Buclizine hydrochloride
(CAS: 129-74-8)

Buclizine hydrochloride is an antihistamine and anticholinergic of the piperazine derivative family.

CAS 147-24-0 Diphenhydramine HCl

Diphenhydramine HCl
(CAS: 147-24-0)

Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a ...

CAS 152241-24-2 GT 2016

GT 2016
(CAS: 152241-24-2)

GT 2016 is a high affinity and brain-penetrant histamine H3 receptor antagonist (Ki = 43.8 nM). It displays selectivity against H1 and H2 receptors (IC50 >10 μM...

Chemical Structure

CAS 118288-08-7 Lafutidine

Quick Inquiry

Verification code

Featured Items